Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3392-7. doi: 10.1073/pnas.0630592100. Epub 2003 Mar 7.

Abstract

Vaccine efficacy is determined largely by cellular and humoral immunity as well as long-lasting immunological memory. IL-2 and IL-15 were evaluated in vaccinia vectors expressing HIV gp160 for the establishment of an effective vaccine strategy. Both IL-2 and IL-15 in the vaccinia vector induced strong and long-lasting antibody-mediated immunity as well as a short-term cytotoxic T cell response against HIV gp120. In addition, IL-15 also supported robust CD8+ T cell-mediated long-term immunity, whereas the CD8+ T cell-mediated immunity induced by IL-2 was short-lived. Moreover, we found that the cytokine milieu at the time of priming had surprisingly persistent effects on the character of the memory CD8 T cells long afterward with respect to their fate, functional activities, cytokine receptor expression, and antigen-independent proliferation.

MeSH terms

  • AIDS Vaccines / administration & dosage*
  • AIDS Vaccines / genetics
  • Animals
  • B-Lymphocytes / immunology
  • Cytotoxicity, Immunologic
  • Female
  • Genetic Vectors
  • HIV Envelope Protein gp160 / genetics
  • HIV Envelope Protein gp160 / immunology
  • Immunity, Cellular*
  • Immunologic Memory
  • In Vitro Techniques
  • Interleukin-15 / genetics*
  • Interleukin-2 / genetics*
  • Killer Cells, Natural / immunology
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • T-Lymphocytes, Cytotoxic / immunology
  • Vaccinia virus / genetics

Substances

  • AIDS Vaccines
  • HIV Envelope Protein gp160
  • Interleukin-15
  • Interleukin-2